Manufacturers: HanchorBio
HCB303 is HanchorBio's next-generation trispecific program, listed in the company's pipeline alongside clinical-stage programs HCB101 and HCB301.
HCB303 is HanchorBio's next-generation trispecific program, listed in the company's pipeline alongside clinical-stage programs HCB101 and HCB301.
